From Atiku Sarki, Abuja
The Executive Director and Chief Executive Officer of the National Primary Health Development Agency (NPHCDA), Dr. Faisal Shuaib has said that by the end of this month and early next month, the country will receive 3, 924, 000 doses of Oxford AstraZeneca from the COCAX facility by the United States Government.
Dr. Shuaib disclosed this while briefing newsmen in Abuja on the progress of Covid-19 vaccination in the nation.
He said that the nation has successfully vaccinated 3, 938, 945 eligible persons across 36 states and the FCT which he said represented 98 per cent utilization of the 4, 024, 000 doses of the vaccine received from COVAX facility in March this year.
In the cause of the exercise, he said, the country recorded 14, 550 cases of Mild/Moderate Adverse Event.
According to him, following immunization, only 148 cases considered being severe, adding that: “We did not record any case to death associated with Covid-19 vaccination.”
He explained that the country has officially ended the first phase of its Covid-19 vaccination and is now preparing to commence the second phase in the next few weeks.
The Executive Director of the agency said that they have also received communication for the delivery of the vaccine shipments in the coming months, including its 3, 924, 000 doses by the end of this month and early next month from the COVAX facility donated by the United States Government and 3, 577, 860 doses of Pfzer-Bio-N Tech Covid-19 vaccine in Q3 as well as 9, 850, 000 doses of Johnson and Johnson (Jessen) Covid-19 vaccine by the end of September which he said would arrive in batches from the African Union Commission.